Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Phenylephrine vs Norepinephrine for Septic Shock
NCT02203630Phase 4Terminated
- Sponsor
- Vanderbilt University Medical Center
- Start
- Aug 2014
- Primary completion
- Jan 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 4 trial of phenylephrine in septic shock, sponsored by Vanderbilt University Medical Center. Started Aug 2014; status: terminated.
02
Drugs
phenylephrine
03
Conditions
septic shock
Beyond the preview
Go deeper on NCT02203630.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02203630.